Previous Chapter Chapter 98: Mexican Markets for Facial Aesthetics Next Chapter
Chapter 98: Mexican Markets for Facial Aesthetics
The Mexican market for facial aesthetics, including botulinum toxins (BTXs) and dermal fillers (hyaluronic acid [HA], particle and polymer fillers, and collagen), was valued at nearly $12 million in 2005. This market will be driven by patient preference for nonsurgical cosmetic procedures, growing disposable incomes, and physician enthusiasm to perform these profitable procedures. In addition, strategic placements for facial aesthetic products such as Botox and Restylane have contributed to patient awareness and demand for these aesthetic products. There are few limiters aside from economic factors.
Over the forecast period, the Mexican facial aesthetic market will be primarily characterized by biting competition between existing competitors across all product segments. While patient ...